Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10SANOFI AVENTIS US
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-10-27
US Patent Number : 12453712
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code : U-4334
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-10-27
US Patent Number : 10583110
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code : U-2753
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-10-27
US Patent Number : 10716777
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code : U-2856
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-10-27
US Patent Number : 8927592
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code : U-3200
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-10
US Patent Number : 7241907
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-12-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-04-27
US Patent Number : 8927592*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-04-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2026-06-10
US Patent Number : 7241907*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-06-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-04-27
US Patent Number : 10583110*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-04-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-04-27
US Patent Number : 10716777*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-04-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-04-27
US Patent Number : 12453712*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 201023
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-04-27
